@warrenbluffet Yes, correct. FDA does not have to approve marketing material. As is here in AU, the TGA will hold you responsible if your marketing does not meet its criteria. However, requiring approval on marketing/advertising material would simply not be feasible. I am the sponsor of a medtech device from Europe and have been through the AU process.
- Forums
- ASX - By Stock
- LDX
- The re-rate journey
The re-rate journey, page-51
-
-
- There are more pages in this discussion • 339 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LDX (ASX) to my watchlist
|
|||||
Last
4.3¢ |
Change
-0.001(2.27%) |
Mkt cap ! $20.69M |
Open | High | Low | Value | Volume |
4.4¢ | 4.4¢ | 4.3¢ | $58.21K | 1.335M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 200000 | 4.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.5¢ | 535000 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 200000 | 0.043 |
4 | 623000 | 0.042 |
3 | 276828 | 0.041 |
3 | 376639 | 0.040 |
1 | 360000 | 0.039 |
Price($) | Vol. | No. |
---|---|---|
0.045 | 535000 | 4 |
0.046 | 894503 | 3 |
0.048 | 218015 | 3 |
0.049 | 200000 | 1 |
0.050 | 200000 | 1 |
Last trade - 15.29pm 16/07/2024 (20 minute delay) ? |
Featured News
LDX (ASX) Chart |